4//SEC Filing
Blueprint Medicines Corp 4
Accession 0001179110-15-014506
CIK 0001597264operating
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 5:16 PM ET
Size
7.0 KB
Accession
0001179110-15-014506
Insider Transaction Report
Form 4
Lengauer Christoph
Chief Scientific Officer
Transactions
- Sale
Common Stock
2015-11-02$21.10/sh−48,264$1,018,370→ 140,068 total - Sale
Common Stock
2015-11-03$20.98/sh−36,734$770,679→ 103,334 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.09 to $21.44 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.07 to $21.90 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001597264
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 5:16 PM ET
- Size
- 7.0 KB